Invention Grant
- Patent Title: Crystalline salt form of an antidiabetic compound
- Patent Title (中): 抗糖尿病化合物的结晶盐形式
-
Application No.: US12529202Application Date: 2008-02-28
-
Publication No.: US08258161B2Publication Date: 2012-09-04
- Inventor: Aquiles E. Leyes
- Applicant: Aquiles E. Leyes
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Anna L. Cocuzzo; Richard C. Billups
- International Application: PCT/US2008/055282 WO 20080228
- International Announcement: WO2008/109334 WO 20080912
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; C07D413/04
Abstract:
A novel crystalline anhydrous toluenesulfonic acid salt form of a selective PPAR gamma partial agonist which has a fused bicyclic aromatic group attached to an oxypropanoic acid moiety is stable and non-hygroscopic. The crystalline salt form is useful for making pharmaceutical formulations for the treatment of type 2 diabetes, hyperglycemia, obesity, and dyslipidemia.
Public/Granted literature
- US20100056580A1 NOVEL CRYSTALLINE SALT FORM OF AN ANTIDIABETIC COMPOUND Public/Granted day:2010-03-04
Information query
IPC分类:
